Published in

Elsevier, The Lancet, 10127(391), p. 1263-1273

DOI: 10.1016/s0140-6736(18)30475-6

Links

Tools

Export citation

Search in Google Scholar

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Journal article published in 2018 by Bruce A. C. Cree, Ludwig Kappos, Anat Achiron, Lutz Achtnichts, Kadriye Agan, Robert J. Fox, Gulsen Akman-Demir, Alison B. Allen, Jack P. Antel, Amit Bar-Or, Alfredo Rodriguez Antiguedad, Michelle Apperson, Angela M. Applebee, Guillermo Izquierdo Ayuso, Masayuki Baba and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO